Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
pinometostat (EPZ-5676)
i
Other names:
EPZ-5676
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Ipsen
Drug class:
DOT1L inhibitor
Related drugs:
‹
EPZ004777 (2)
EPZ004777 (2)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
DNMT3A mutation
Acute Myelogenous Leukemia
DNMT3A mutation
Acute Myelogenous Leukemia
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
AR-V7 expression
Prostate Cancer
AR-V7 expression
Prostate Cancer
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
ALDH1A1 positive
Triple Negative Breast Cancer
ALDH1A1 positive
Triple Negative Breast Cancer
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
EPZ-5676
Sensitive: D – Preclinical
EPZ-5676
Sensitive
:
D
MLL rearrangement
Leukemia
MLL rearrangement
Leukemia
VTP-50469 + EPZ-5676
Sensitive: D – Preclinical
VTP-50469 + EPZ-5676
Sensitive
:
D
VTP-50469 + EPZ-5676
Sensitive: D – Preclinical
VTP-50469 + EPZ-5676
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login